Therapeutic effects of mucosal tolerance on experimental colitis in rats

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 10, 2009, Pages 1145-1152

  Shan Shan, Zhang ^a   Yu Lan, Liu ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Adjuvant; Colitis; Mucosal tolerance; Regulatory T cell; Trinitrobenzenesulphonic acid

Indexed keywords

ENEMA; LIPOPOLYSACCHARIDE; OVALBUMIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3; TRINITROBENZENESULFONIC ACID; ANTIGEN; IMMUNOLOGICAL ADJUVANT; TOLL LIKE RECEPTOR;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; COLITIS; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; MALE; MONONUCLEAR CELL; MOUTH MUCOSA; MUCOSAL TOLERANCE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY T LYMPHOCYTE; SPLEEN CELL; THERAPY EFFECT; UPREGULATION; ANIMAL; CHEMICALLY INDUCED; DESENSITIZATION; DISEASE MODEL; EVALUATION STUDY; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; INTESTINE MUCOSA; INTRANASAL DRUG ADMINISTRATION; METABOLISM; MUCOSAL IMMUNITY; ORAL DRUG ADMINISTRATION; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIGENS; COLITIS; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MALE; OVALBUMIN; RATS; RATS, SPRAGUE-DAWLEY; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTORS; TRINITROBENZENESULFONIC ACID;

EID: 70349745822     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32830edb29     Document Type: Article

References (34)

1. Ouyang Q, Tandon R, Goh KL, Pan GZ, Fock KM, Fiocchi C, et al. Management consensus of inflammatory bowel disease for the Asia-Pacific region. J Gastroenterol Hepatol 2006; 21:1772-1782. (Pubitemid 44656996)
2. Kucharzik T, Maaser C, Lügering A, Kagnoff M, Mayer L, Targan S, et al. Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis 2006; 12:1068-1083. (Pubitemid 44665477)
3. Nakamura K, Honda K, Mizutani T, Akiho H, Harada N. Novel strategies for the treatment of inflammatory bowel disease: selective inhibition of cytokines and adhesion molecules. World J Gastroenterol 2006; 12:4628-4635. (Pubitemid 44269718)
4. Faria AM, Weiner HL. Oral tolerance. Immunol Rev 2005; 206:232-259.
5. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 1996; 183:2605-2616. (Pubitemid 26192369)
6. Ilan Y,Weksler-Zangen S, Ben-Horin S, Diment J, Sauter B, Rabbani E, et al. Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes. Am J Gastroenterol 2000; 95:966-973. (Pubitemid 30196733)
7. Hyun JG, Barrett TA. Oral tolerance therapy in inflammatory bowel disease. Am J Gastroenterol 2006; 101:569-571. (Pubitemid 43340934)
8. Kraus TA, Toy L, Chan L, Childs J, Mayer L. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 2004; 126:1771-1778. (Pubitemid 38736342)
9. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96:795-803.
10. Butzner JD, Parmar R, Bell CJ, Dalal V. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 1996; 38:568-573. (Pubitemid 26111377)
11. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Peña AS, Meuwissen SG, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998; 114:385-391. (Pubitemid 28539597)
12. Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 2000; 243:147-154.
13. Kraus TA, Mayer L. Oral tolerance and inflammatory bowel disease. Curr Opin Gastroenterol 2005; 21:692-696. (Pubitemid 41578645)
14. Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, et al. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 1997; 18:61-64. (Pubitemid 27107097)
15. Ning C, Peng Y, An-nan L, Yu-lan L. The influence of T regulatory cells on experimental colitis in rats after treatment by probiotics. Chin J Dig 2006; 26:100-103.
16. Andrade MC, Vaz NM, Faria AM. Ethanol-induced colitis prevents oral tolerance induction in mice. Braz J Med Biol Res 2003; 36:1227-1232.
17. Andrade MC, Menezes JS, Cassali GD, Martins-Filho OA, Cara DC, Faria AM. Alcohol-induced gastritis prevents oral tolerance induction in mice. Clin Exp Immunol 2006; 146:312-322. (Pubitemid 44581347)
18. Zheng YQ,Wei W, Shen YX, Dai M, Liu LH. Oral and nasal administration of chicken type II collagen suppresses adjuvant arthritis in rats with intestinal lesions induced by meloxicam. World J Gastroenterol 2004; 10: 3165-3170. (Pubitemid 39419880)
19. Bai XF, Link H. Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine. Clin Exp Allergy 2000; 30:1688-1696. (Pubitemid 32011747)
20. Holmgren J, Adamsson J, Anjuère F, Clemens J, Czerkinsky C, Eriksson K, et al. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol Lett 2005; 97:181-188. (Pubitemid 40326949)
21. Khoury SJ, Hancock WW,Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992; 176:1355-1364.
22. Newby TJ, Stokes CR, Bourne FJ. Effects of feeding bacterial lipopolysaccharide and dextran sulphate on the development of oral tolerance to contact sensitizing agents. Immunology 1980; 41:617-621.
23. Allez M, Mayer L. Regulatory T cells: peace keepers in the gut. Inflamm Bowel Dis 2004; 10:666-676. (Pubitemid 39276480)
24. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-1061. (Pubitemid 36222930)
25. +CD28 T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum Immunol 2006; 67:1-12.
26. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2:675-680. (Pubitemid 32747155)
27. Sutmuller RP, Den Brok MH, Kramer M, Bennink EJ, Toonen LW, Kullberg BJ, et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006; 116:485-494. (Pubitemid 43228366)
28. Lotz M, Gütle D, Walther S, Ménard S, Bogdan C, Hornef MW. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 2006; 203:973-984.
29. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68:7010-7017. (Pubitemid 32463415)
30. Cario E. Bacterial interactions with cells of the intestinal mucosa: toll-like receptors and NOD2. Gut 2005; 54:1182-1193. (Pubitemid 41025918)
31. Fujisawa M, Kiyosue M, Hori M, Ozaki H. Identification of Card15/Nod2 mRNA in intestinal tissue of experimentally induced colitis in rats. J Vet Med Sci 2006; 68:701-708. (Pubitemid 44198575)
32. Muthukuru M, Jotwani R, Cutler CW. Oral mucosal endotoxin tolerance induction in chronic periodontitis. Infect Immun 2005; 73:687-694. (Pubitemid 40165723)
33. Otte JM, Cario E, Podolsky DK. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 2004; 126:1054-1070. (Pubitemid 38451177)
34. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003; 197:403-411. (Pubitemid 36278597)